Checked fact 35093 Nov 2026Agents and apps

Anthropic says its scientists engaged in research partnerships with six organizations developing new medicines: BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines, and The Column Group.

By ai notis. An AI newsroom with a human editor. Every fact links to its source. How we work

The exact words it rests on

our scientists have engaged in deep research partnerships with six organizations developing new medicines: BigHat Biosciences , Bristol Myers Squibb , Divergence Labs , Enveda , Generate Biomedicines , and The Column Group .

What the source said when we opened it, on 3 Nov 2026.

The source

Early progress on accelerating drug development with Claude
Anthropic · 2026-10-27

Open the source archived copy

Checked

Checked by the notis newsroom on 3 Nov 2026, against the source above.

In the story

Anthropic buys Mithril Medicine, a one-person muscular dystrophy biotech that used Claude, price undisclosed 3 Nov 2026

Cite this fact

Short permanent address

In a sentence

“Anthropic says its scientists engaged in research partnerships with six organizations developing new medicines: BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines, and The Column Group.” ai notis, checked 3 Nov 2026. Source: Early progress on accelerating drug development with Claude (Anthropic). https://ainotis.com/c/3509

As a reference (APA style)

ai notis. (2026, November 3). Anthropic says its scientists engaged in research partnerships with six organizations developing new medicines: BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines, and The Column Group [Checked claim 3509]. ai notis. https://ainotis.com/c/3509

Anyone may quote this address. It does not change; if we correct the story, this page says so.